Cargando…
A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations
PURPOSE: To investigate the utility of biomarkers of maturity-onset diabetes of the young (MODY), high-sensitivity C-reactive protein (hsCRP), and 1,5-anhydroglucitol (1,5-AG) in conjunction with other clinical and laboratory features to improve diagnostic accuracy and provide a diagnostic algorithm...
Autores principales: | Szopa, Magdalena, Klupa, Tomasz, Kapusta, Maria, Matejko, Bartlomiej, Ucieklak, Damian, Glodzik, Wojciech, Zapala, Barbara, Sani, Cyrus Maurice, Hohendorff, Jerzy, Malecki, Maciej T., Skupien, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453873/ https://www.ncbi.nlm.nih.gov/pubmed/30778899 http://dx.doi.org/10.1007/s12020-019-01863-7 |
Ejemplares similares
-
A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus
por: Hohendorff, J., et al.
Publicado: (2017) -
Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes
por: Szopa, Magdalena, et al.
Publicado: (2015) -
Insulin pump settings and glucose patterns during a 1008-km non-stop bicycle race in a patient with type 1 diabetes mellitus
por: Klupa, Tomasz, et al.
Publicado: (2018) -
Assessment of Newly Proposed Clinical Criteria to Identify HNF1A MODY in Patients with an Initial Diagnosis of Type 1 or Type 2 Diabetes Mellitus
por: Grzanka, Malgorzata, et al.
Publicado: (2016) -
Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump
por: Ucieklak, Damian, et al.
Publicado: (2022)